Ken Griffin Bio Affinity Technologies, Inc. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding BIAF
# of Institutions
15Shares Held
494KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA261KShares$203,4770.0% of portfolio
-
Geode Capital Management, LLC Boston, MA87.2KShares$68,0010.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC46.3KShares$36,1170.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$21,7500.0% of portfolio
-
State Street Corp Boston, MA17.6KShares$13,7280.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $2.13M
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...